Effects of Butylparaben Exposure on Pancreatic Development in Zebrafish (Danio rerio) Embryos by Brown, Sarah E
University of Massachusetts Amherst 
ScholarWorks@UMass Amherst 
Masters Theses Dissertations and Theses 
November 2016 
Effects of Butylparaben Exposure on Pancreatic Development in 
Zebrafish (Danio rerio) Embryos 
Sarah E. Brown 
University of Massachusetts Amherst 
Follow this and additional works at: https://scholarworks.umass.edu/masters_theses_2 
Recommended Citation 
Brown, Sarah E., "Effects of Butylparaben Exposure on Pancreatic Development in Zebrafish (Danio rerio) 
Embryos" (2016). Masters Theses. 411. 
https://scholarworks.umass.edu/masters_theses_2/411 
This Open Access Thesis is brought to you for free and open access by the Dissertations and Theses at 
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Masters Theses by an authorized 
administrator of ScholarWorks@UMass Amherst. For more information, please contact 
scholarworks@library.umass.edu. 
i 
 
 
 
 
 
Effects of Butylparaben Exposure on Pancreatic Development in Zebrafish (Danio rerio) 
Embryos  
 
 
 
 
 
 
A Thesis Presented 
 
by 
 
SARAH E. BROWN 
 
 
 
 
 
 
Submitted to the Graduate School of the University of Massachusetts Amherst in partial 
fulfillment of the requirements for the degree of 
 
MASTER OF SCIENCE 
 
 
 
 
 
 
September 2016 
 
Environmental Health Sciences
 
 
 
 
 
 
 
 
 
 
 
 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Sarah E. Brown 2016 
All Rights Reserved 
iii 
 
Effects of Butylparaben Exposure on Pancreatic Development in Zebrafish (Danio rerio) 
Embryos  
 
 
 
 
 
A Thesis Presented 
 
by 
 
SARAH E. BROWN 
 
 
 
 
 
 
 
Approved as to style and content by:  
 
 
_________________________________________________  
Alicia R. Timme-Laragy, Chair 
 
 
 _________________________________________________  
Laura N. Vandenberg, Member  
 
 
_________________________________________________  
Alexander V. Suvorov, Member 
 
 
 
 
 
___________________________________________  
Edward J. Stanek III, Department Chair, Department     
of Environmental Health Sciences 
 
 
 
 
 
 
 
iv 
 
ACKNOWLEDGMENTS 
I would like to thank my thesis advisor, Dr. Alicia Timme-Laragy, for this incredible 
opportunity. Working with Dr. Timme-Laragy has been life-changing, and through her 
guidance and with her support, I have learned so much and have accomplished milestones 
that I before only dreamed of accomplishing. I want to thank Dr. Timme-Laragy for always 
being there for me. The challenges that she has put in front of me have given me the 
confidence that I can overcome any challenges  I may encounter in the future. I feel 
extraordinarily lucky to have had the opportunity to work for her and with her. 
I would also like to thank Dr. Karilyn Sant who has been a mentor, a big sister, and 
more importantly an incredible friend. None of this would have been possible without Dr. 
Sant’s help and support. From laboratory work to writing, Dr. Sant’s  help and guidance has 
contributed in shaping me into the professional scientist that I am now. I would also like to 
thank Dr. Sant for running the HPLC on my samples, providing the valuable redox data 
presented here.  
I would also like to thank Dr. Carol Bigelow for her guidance in the statistical 
analysis of the data presented in this thesis. And I would also like to thank Dr. Ling Zhao for 
providing the butylparaben used in these studies as a generous gift. I would also like to thank 
Dr. Craig Harris for providing the facilities to perform the HPLC that produced the redox 
data presented in this thesis.  
I would also like to thank Dr. Paul Kostecki for introducing me to the Environmental 
Health Science’s program. Dr. Kostecki has also been an influential mentor and his guidance 
over the past two years has been greatly valuable.  
I would lastly like to thank my family and friends for their never-ending support; 
without them none of this would have been possible.  
 
v 
 
ABSTRACT 
EFFECTS OF BUTYLPARABEN EXPOSURE ON PANCREATC DEVELOPMENT 
IN ZEBRAFISH (Danio rerio) EMBRYOS 
 
SEPTEMBER 2016 
 
SARAH E. BROWN, B.S., SAINT MICHAEL’S COLLEGE 
 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Alicia R. Timme-Laragy 
 
Butylparaben (Butyl p-hydroxybenzoic acid) is a widely used cosmetic and 
pharmaceutical preservative that has been recently shown to induce oxidative stress and 
have endocrine disrupting effects in rodents, and promote adipocyte conversion of human 
adipose cells. Embryonic development is extremely sensitive to oxidative stress due to 
changes in cell growth, development and differentiation that occur during this life stage. 
Fluctuations in redox potentials play critical roles in normal embryonic development by 
guiding these cell signaling, cell-fate decisions and apoptosis. The most prevalent 
endogenous antioxidant that defends against oxidative stress is glutathione (GSH), which 
scavenges reactive oxygen species. The low antioxidant capacity of pancreatic beta cells 
suggests that they are sensitive target tissues of oxidative stress; this has yet to be 
investigated during embryonic development. Here, we aim to 1) determine whether 
embryonic exposure to butylparaben prompts structural and functional changes in the 
developing endocrine pancreas and 2) determine whether oxidative stress may be 
involved. Transgenic insulin-GFP zebrafish embryos were treated daily with 250, 500, 
1,000 and 3,000 nM butylparaben starting at 3 hours post fertilization (hpf). Pancreatic 
islet and whole embryo morphological development were examined daily until 7 days 
post fertilization (dpf). Redox potentials were measured at 24 and 28 hpf using HPLC.  
vi 
 
Area of the pancreatic islet increased over time with increasing butylparaben exposure in 
a dose-dependent manner by as much as a 55% increase in islet area at 3 dpf when 
compared to controls. Butylparaben concentrations of 500 and 1,000 nM increased GSH 
by 10 and 40%, respectively, and decreased oxidized glutathione disulfide by 37 and 
59%. GSH redox potentials were only significant in embryos collected at 28 hpf and 
became more reduced with 500 and 1,000 nM butylparaben exposure, decreasing redox 
potentials by 7 and 18 mV, respectively. Cysteine redox potentials also became more 
reduced, decreasing by 17 and 28 mV. Our data show that butylparaben-induced redox 
potential disruptions that may be responsible for the effects on pancreatic islet structure 
and function, but further studies are needed to determine how and if that directly affects 
pancreas development. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1. Diabetes 
Over the past few decades, the incidence of diabetes has been rapidly increasing 
worldwide. According to the Centers for Disease Control, in the United States alone, the 
prevalence of diagnosed diabetes has increased 176% from 1980 to 2011. Type 2 diabetes 
(T2D) is currently the seventh leading cause of death in the United States (Pitkaniemi, et 
al 2004). Diabetes has often been characterized as a disease that affects the populations 
of developed countries, resulting from a sedentary lifestyle. However, according to the 
International Diabetes Federation, today four out of five people with diabetes now live in 
developing countries. According to the World Health Organization, people in developing 
countries are also exposed to greater amounts of environmental pollutants. This increased 
prevalence of T2D diabetes in genetically stable populations indicates the presence of a 
strong environmental component that is influencing this escalation (Pitkaniemi et al 
2004). T2D develops from impaired insulin signaling that leads to the pancreas’s inability 
to maintain normal glucose homeostasis, and compensate for the body’s resistance to 
insulin. This compensation often fails due to mitochondrial dysfunction and endoplasmic 
reticular stress, leading to beta cell apoptosis (Makaji et al 2011). Developmental 
exposures to environmental factors may affect the development of the pancreas, 
predisposing individuals to T2D later in life. 
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 1.2. The Pancreas 
The pancreas is an endoderm-derived organ that consists of both exocrine and 
endocrine tissues. The exocrine acinar tissues are mainly responsible for producing 
digestive enzymes, whereas the endocrine islets of Langerhans produce hormones that 
maintain glucose homeostasis. The pancreatic islets are comprised of a central core of 
beta cells that produce insulin, surrounded by alpha, delta and epsilon cells that produce 
the hormones glucagon, somatostatin and ghrelin respectively (Kinkel et al, 2009). The 
hormones of the endocrine pancreas work together to maintain glucose homeostasis: 
insulin inhibits the secretion of glucagon from alpha cells, while glucagon activates the 
secretion of insulin and somatostatin from beta and delta cells, whereas somatostatin and 
ghrelin inhibit insulin secretion (Figure 1) (Jiang et al, 2011). 
 
Figure 1. The endocrine pancreatic hormones insulin, somatostatin, glucagon and 
ghrelin are responsible for the regulation of glucose homeostasis. Insulin (mainly 
responsible for glucose homeostasis) inhibits glucagon secretion from alpha cells. 
Glucagon activates the secretion of insulin and somatostatin, whereas somatostatin and 
ghrelin inhibit insulin secretion. (Jiang et al, 2011) 
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The zebrafish pancreas is structurally similar to the mammalian pancreas, and 
shares the same cellular makeup (Kinkel et al, 2009). During development, the pancreas 
arises from the endoderm germ layer (from which the liver, gallbladder and intestine are 
also derived) and differentiates into the exocrine and endocrine tissues (Warga et al, 
1999). At the 24 somite stage of the developing zebrafish, the islet precursor cells of the 
pancreas arise from endodermal progenitor cells and bud off dorsally from the gut, giving 
rise to endocrine tissues that express insulin, along with other pancreatic hormones (Tiso 
et al, 2009). Between 24 and 48 hours post fertilization (hpf), the rotating gut dislocates 
this dorsal bud on the right side of the gut, forming an islet that is organized similarly to 
the mammalian islet by 48 hpf (Tiso et al, 2009 and Biemar et al, 2001). The mature 
zebrafish endocrine pancreas forms around 7 days post fertilization (dpf) and consists of 
an organized mass of beta cells, surrounded mainly by alpha and delta cells that make up 
the primary islet (Figure 2), and smaller secondary islets that are nested in the exocrine 
tissues (Tiso et al, 2009). 
Mammalian in utero systems do not allow for the direct observation of in vivo 
organ, especially pancreatic, development. Organogenesis cannot be directly visualized 
within the mammalian uterus, and tissue sampling is often invasive. In contrast, zebrafish 
embryos are see-through, and do not develop in utero, allowing for the direct observation 
of organ and whole-embryo development in vivo. As a result, the zebrafish model is 
becoming increasingly used for developmental research, due to this species’ rapid 
developmental growth, the numerous existing transgenic lines, and transparent embryos 
that allow for real time imaging of morphologic development (Lieschke et al, 2007). 
Because of these characteristics, the zebrafish has become a well-established model used 
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to study human development and disease, including pancreatic development and 
developmental glutathione redox dynamics (Tiso et al, 2009 and Timme-Laragy et al, 
2013).  
The Transgenic (ins-GFP) zebrafish line was created so that insulin expression is 
represented by Green Fluorescent Protein (GFP) (diIorio et al, 2002). This line was first 
generated by injecting approximately 5 nL containing 20 ng/L cesium-purified plasmid 
DNA and 50 ng/mL Tc3A transposase mRNA into zebrafish embryos at the one to two 
cell stage, creating single-copy insertions (diIorio et al, 2002). As a result, fluorescence 
occurs whenever preproinsulin is transcribed, creating GFP as a marker in pancreatic beta 
cells. Because beta cells produce insulin, during embryonic development, this is an ideal 
strain that allows for the visualization and imaging of the endocrine pancreas in vivo in 
real-time. 
 
 
 
 
 
 
 
 
 
 
Figure 2. Location, organization and composition of the adult zebrafish pancreatic islet 
(Kinkel et al, 2009). 
 
1.3. Oxidative Stress 
One factor implicated in T2D is oxidative stress. As defined by Jones et al, 2006, 
oxidative stress is the “disruption of redox signaling and control.” Intrauterine oxidative 
stress is known to be associated with an increased risk of developing T2D later in life 
(Simmons et al, 2006). Due to their low expression of antioxidant enzymes, such as 
Figure 2. Location, organization and composition of the adult zebrafish pancreatic islet. 
(Kinkel et al, 2009) 
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superoxide dismutase, catalase, glutathione and glutathione peroxidase, pancreatic beta 
cells are especially sensitive to oxidative stress (Lenzen et al, 1996). The most prevalent 
endogenous antioxidant that defends against oxidative stress is glutathione (GSH), a 
tripeptide of cysteine, glutamate and glycine. GSH is synthesized via two ATP-dependent 
steps: 1) the enzyme glutamate-cysteine ligase (Gcl) combines glutamate and cysteine in 
the rate-limiting step; 2) a glycine is added to the glutamate-cysteine molecule in a 
reaction catalyzed by glutathione synthase (Gss) (Figure 3). GSH defends against 
oxidative stress by scavenging reactive oxygen species (ROS) which oxidize the cysteine 
moiety, and by acting as a co-factor for the antioxidant enzymes glutathione-S-transferase 
(Gst) and glutathione peroxidase (Gpx) (Timme-Laragy et al, 2013). When GSH is 
oxidized, it dimerizes and becomes glutathione disulfide (GSSG), which can be recycled 
back into reduced glutathione (GSH) in a NADPH-dependent reaction, catalyzed by the 
enzyme glutathione disulfide reductase (Gsr) (Figure 3) (Timme-Laragy et al, 2013).  
Measured concentrations of GSH and GSSG can be applied to the Nernst equation 
to calculate redox potentials (Eh) (Jones et al, 2006). Fluctuations in redox potentials play 
an important role in normal embryonic development by guiding cell signaling, cell-fate 
decisions and apoptosis (Hansen et al, 2013). More positive redox potentials indicate a 
more oxidized redox state and are associated with cell differentiation and apoptosis, 
whereas more negative redox potentials suggest a more reduced redox state and are 
associated with cell proliferation (Schafer et al, 2001). Embryonic exposure to 
environmental anthropogenic chemicals, such as parabens, may generate ROS that 
disturb redox signaling and affect intracellular redox potentials, altering cell fate 
decisions, and potentially leading to disrupted pancreatic islet structure and function.  
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Figure 3. Glutathione synthesis and use. (Timme-Laragy et al, 2013) 
1.4. Butylparaben 
Parabens (para-hydroxybenzoic acids) are a family of alkyl esters that are 
currently the most widely used preservatives in cosmetic and pharmaceutical products 
due to their extensive range of antimicrobial activity. In fact, parabens are the most 
common cosmetic ingredient after water (Cashman et al, 2005).  Butylparaben is one of 
the most commonly used parabens in commercial products after methyl- and 
propylparaben. However, only a few studies have been conducted that investigate an 
association between butylparaben and oxidative stress. Butylparaben has been found to 
induce oxidative stress in the liver tissues of mice by significantly decreasing GSH 
(43.87%) along with the enzymatic activities of GSH peroxidases and GSH-S-
transferases (Shah et al, 2012). A study that measured GSH redox dynamics in the brain 
tissues of developmentally exposed mouse offspring also found GSH and the GSH/GSSG 
percent ratio to decrease and GSSG and percent GSSG to increase, suggesting the 
occurrence of oxidative stress (Hegazy et al, 2015). Urinary butylparaben levels have 
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been shown to be associated with biomarkers of oxidative stress in humans (Kang et al, 
2013). Watkins et al (2015) also found urinary butylparaben concentrations to be 
significantly associated with 27 percent higher isoprostane (a urinary marker of oxidative 
stress) and weakly associated with OHdG (a marker of oxidative stress to DNA).  
Often combined to enhance antimicrobial effects, parabens differ due to the 
specific R-group at the para position on the molecule’s benzene ring (Figure 4). The most 
commonly used parabens are methyl-, ethyl, propyl-, benzyl-, and butyl-paraben. The 
different alkyl groups give parabens a spectrum of antimicrobial effects with 
antimicrobial activity and lipophilicity increasing with the length of the alkyl group 
(Cashman et al, 2005). Parabens have been found to act as preservatives by increasing the 
impermeability of bacterial cell membranes to proteins and other ions, and by penetrating 
the phospholipid bilayer of bacterial cell membranes, displacing the phospholipid 
molecules (Eklund et al, 1980). Parabens also obstruct amino acid uptake in bacterial 
membrane vesicles, inhibiting bacterial growth, and have been found to interfere with 
both RNA and DNA synthesis in bacteria (Eklund et al, 1980 and Nes et al, 1983).  
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Figure 4. Chemical structures of seven different parabens. (Darbre et al, 2008) 
 
Humans are most commonly exposed to parabens dermally. However, after all 
routes of exposure, parabens are metabolized by carboxylesterases in the skin, liver, 
linings of the intestine, and subcutaneous fat into metabolites: p-carboxyphenyl 
glucuronide, p-hydroxybenzoyl glucuronide, and p-carboxyphenyl sulfate (Cashman et 
al, 2005 and Soni et al, 2005). These carboxylesterase enzymes are both expressed and 
active in zebrafish embryos as early as the 6 somite stage (Kuster et al, 2005). 
Conventionally, it has been assumed that parabens are quickly absorbed and metabolized, 
which originally contributed to the belief that parabens have low human toxicity. 
However, parabens have been found to escape metabolism in the skin and intestine and 
have been found in human urine, blood serum, and breast milk samples. Ye et al (2006) 
discovered free, un-metabolized butylparaben in 69% of urine samples from subjects with 
no known occupational exposures. Free butylparaben (an average of 135 µg/L) was also 
found in the serum of young male volunteers who were exposed to cosmetics containing 
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butylparaben for one week (Janjua et al, 2007).  Jimenez-Diaz et al (2011) also detected 
an average of 0.4 ng/g
-1
 free butylparaben in human placental tissues.   
A 1995 survey conducted on 215 cosmetic products found parabens in 99% of 
leave-on cosmetics and 77% of rinse-off products (Rastogi et al, 1995). As of 2005, the 
United States population is exposed to an average of 76 mg of parabens per day, with 
butylparaben being the third most abundant exposure (Cashman et al, 2005). Early 
estimates of human exposures to butylparaben in the United States due to long-term 
cosmetic use range from 0.26 to 14.6 mg/day (Masten, et al 2005). In 2014, estimates of 
the daily usage of cosmetic products that contain parabens were 17,760 mg for adults and 
378 mg for infants (Anderson, 2008). According to the United States Food and Drug 
Administration’s Center for Food Safety and Applied Nutrition, the United States 
population consumes an average rate of 37 ng butylparaben per day. Parabens have also 
been detected in adult urine samples as well as in the amniotic fluid of pregnant women 
(0.3 µg/L) (Philippat et al, 2013), suggesting the potential for direct human fetal exposure 
to parabens.  
Parabens have also been shown to have endocrine disrupting effects. 
Butylparaben has been found to interfere with the male and female reproductive system 
by acting as a weak estrogenic chemical, and by hindering spermatogenesis. 
Butylparaben was found to compete with [3H] estradiol for binding to estrogen receptors 
in female rats, and revealed estrogenic responses in sexually mature rainbow trout 
(Routledge et al, 1998, Pedersen et al, 2000). In both male rats and mice, butylparaben 
exposure lowered serum testosterone in a dose-dependent manner, while decreasing 
sperm count and daily sperm production (Oshi et al, 2001, and Oshi et al, 2002).  
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Butylparaben has also been found to increase the release of the adipocyte 
hormones leptin, resistin, and adiponectin through increased peroxisome proliferator-
activated receptor (PPARγ) activation (Taxvig et al, 2012). PPARγ is mainly expressed 
in adipose tissues where it influences the storage of fatty acids and induces adipocyte 
differentiation (Tontonoz et al, 1995). Because PPARγ plays a role in the regulation of 
adipocyte differentiation, Taxvig et al show that, through PPARγ activation, 
butylparaben stimulates lipid accumulation in differentiating adipocytes, which results in 
an increase in the release of adipocyte related hormones. Hu et al (2013) also found 
butylparaben to enhance adipocyte differentiation, increasing glucocorticoid activity in 
addition to activating PPARγ. The potency of these effects was amplified with increasing 
paraben alkyl chain length, with butylparaben displaying the largest magnitude of effect. 
Obesity is known to be associated with an increased risk in developing T2D 
(Kahn et al, 2006). The hormones leptin, adiponectin and resistin are all associated with 
increased insulin resistance and increased risk for developing diabetes (Taxvig et al, 
2012). Increased levels of circulating leptin has been associated with obesity,  however 
low fetal leptin levels may increase the risk of obesity and insulin resistance later in life 
(Djiane et al, 2008). Adiponectin shows an inverse association with insulin resistance 
(Taxvig et al, 2012). Resistin has been shown to regulate insulin sensitivity and 
metabolism in different tissues (Steppan et al, 2001).  Due to its interactions with 
estrogen receptors, interfaces with hormones that are associated with insulin resistance, 
and increased adipocyte differentiation, butylparaben may disrupt endocrine system 
function.  
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To date, no studies have been conducted that examine the effects of butylparaben 
in the zebrafish model (Danio renio); however studies have been conducted using 
propylparaben. Mikula et al, (2008) found that juvenile zebrafish exposed to 500 mg/kg⁻¹ 
propylparaben, administered in feed three times daily, influenced sex differentiation by 
significantly skewing the sex ratio towards the female sex, suggesting propylparaben’s 
ability to interfere with gonad development. Because sex differentiation in zebrafish is 
influenced by hormones, this skewed sex ratio is most likely due to propylparaben’s 
interference with the hypothalamo-pituitary-gonadal axis, suggesting endocrine 
disrupting effects of parabens in vertebrates.  
It is unknown whether butylparaben affects the developing pancreas. A 
preliminary study in 1956 found butylparaben esters recovered in the pancreas of dogs 
that were intra-venously administered 100 mg/kg butylparaben per day (Jones et al, 
1956). However, no further studies have been conducted to investigate whether 
butylparaben affects the developing pancreas. Because pancreatic beta cells have low 
antioxidant levels and gene expression, they are more likely susceptible to oxidative 
damage than the other cell types in the exocrine pancreas. This thesis tests the hypothesis 
that daily butylparaben exposure will alter the development of the endocrine pancreas 
with the possible involvement of oxidative stress.   
1.5. Thesis Overview 
This study aims to determine whether butylparaben may prompt structural and 
functional changes in the beta cells of the endocrine pancreas, and to investigate whether 
butylparaben induces oxidative stress in the developing zebrafish.  Chapter 2 examines 
how embryonic butylparaben exposure affects endocrine pancreatic development and 
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whole embryo morphological development in transgenic (ins-GFP) zebrafish. Embryos 
were imaged at 3, 4, 5 and 7 days post fertilization; islet areas were measured and islet 
deformities were quantified to determine whether butylparaben affects islet development 
by altering islet area and morphology. Yolk sac area was also measured throughout 
development to indicate metabolism and to determine the rate at which exposed embryos 
utilize nutrients. Other morphological deformities were also quantified to determine 
whether pancreatic islets are specifically sensitive to butylparaben. Gene expression of 
the endocrine pancreatic hormone index was also quantified. 
Chapter 3 identifies the impact of butylparaben on glutathione redox dynamics in 
embryonic zebrafish. GSH and GSSG were quantified to determine redox potentials in 
transgenic (ins-GFP) zebrafish embryos. Embryos endured exposures to 500 nM and 
1,000 nM butylparaben and were collected for redox analysis at 24 and 28 hpf. Redox 
potentials were determined using HPLC detection of soluble thiols. Expression of the 
genes involved in glutathione synthesis, and utilization, including glutamate cystine 
ligase subunits (gclc and gclm), glutathione synthetase (gss), glutathione disulfide 
reductase (gsr) and glutathione S-transferase (gst) were measured at 3 days post 
fertilization via qPCR, using β-actin as a housekeeping gene1. These studies aim to 
determine: 1) whether embryonic exposure to butylparaben prompts structural and 
functional changes in the developing endocrine pancreas and 2) determine whether 
butylparaben induces oxidative stress that may contribute to islet morphology. 
1
Regarding the gene and protein name formatting, the approved format for designing 
genes and proteins (see the ZFIN Zebrafish Nomenclature Web site 
https://wiki.zfin.org/display/general/ZFIN+Zebrafish+Nomenclature+Guidelines) was 
used. Human genes and proteins are labeled using all capitals (INSA and INSA 
respectively), and rodent genes and proteins are labeled Insa and INSA respectively. 
Zebrafish genes and proteins are characterized as insa and Insa respectively.  
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CHAPTER 2 
 
BURYLPARABEN ALTERS THE DEVELOPING PANCREAS 
 
2.1. Introduction  
 Over the past few decades, the incidence of both Type 1 and Type 2 diabetes has 
greatly increased in genetically stable populations, suggesting influential environmental 
factors are contributing to this escalation. Early life exposures to environmental 
chemicals may impact the development of the endocrine pancreas, and may contribute to 
this escalated prevalence (Pitkaniemi et al, 2004). The pancreas is highly vascularized, 
and is therefore likely exposed to environmental chemicals that are in the bloodstream. 
Two main tissues make up the pancreas: the exocrine acinar tissues that produce 
digestive enzymes, and endocrine islets of Langerhans that are composed of different 
cells that produce hormones involved in the regulation of glucose homeostasis (Jiang et 
al, 2011). The alpha cells of the endocrine islets produce glucagon that signals the 
degradation of molecules such as glycogen for the production of free glucose. Epsilon 
and delta cells produce ghrelin and somatostatin respectively, which negatively regulate 
insulin and glucagon secretion. The beta cells of the endocrine pancreas are the only cells 
that produce insulin, which promotes the absorption of glucose from the bloodstream 
(Jiang et al, 2011). The transcription factor Pdx1 transcribes for both insulin and 
glucagon.  
 The zebrafish pancreas is structurally similar to the mammalian pancreas and 
shares this same cellular make-up (Kinkel et al, 2009). The zebrafish model is commonly 
used in developmental toxicological research, especially due this model’s plethora of 
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different transgenic lines. Here, using the transgenic ins-GFP line, the developing 
pancreas can be observed in vivo in real time. 
 Butylparaben has been recovered in pancreatic tissues, and has been found in 
human amniotic fluid, suggesting the possibility of direct human fetal and pancreas 
exposure (Jones et al, 1956 and Philippat et al, 2013). To date, there are no studies that 
observe whether butylparaben affects the developing pancreas. This study aims to 
identify whether daily exposure to different environmentally relevant concentrations of 
butylparaben affect the development of the endocrine pancreas in the zebrafish model. 
Embryos were exposed daily to different environmentally relevant concentrations of 
butylparaben and were imaged for pancreas and morphological deformities at time points 
that are critical to pancreatic and embryonic development. Islet areas were also measured 
and the incidences of islet deformities were calculated.  
The developing islet is easily disrupted by any morphological deformities that 
may be a consequence of butylparaben exposure. Therefore, embryonic gross 
development was analyzed by measuring nose-to-tail embryonic length and yolk sac area 
to indicate the embryos’ utilization of nutrients. The incidence and severity of 
morphological deformities were also accounted for in a deformity index, and the 
occurrence of morphological deformities were compared to the incidence of islet 
deformities. Gene expression of the hormones involved in the regulation of insulin 
homeostasis (glucagon, somatostatin, insulin and ghrelin) were measured along with the 
transcription factor Pdx1. These experiments aim to determine whether butylparaben 
prompts structural changes in the developing zebrafish pancreas.  
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2.2 Materials and Methods 
2.2.1 Chemicals  
Butylparaben (Acros Organics, Thermo Fisher Scientific, Pittsburg, PA) was 
acquired as a generous gift from Dr. Ling Zhao (Department of Nutrition, University of 
Tennessee Knoxville, Knoxville, TN) dissolved in 0.01% v/v Dimethyl Sulfoxide 
(DMSO) (Fischer Scientific, Pittsburg, PA). Solutions were stored at -20 ºC and vortexed 
before each use.  
2.2.2 Zebrafish Husbandry 
Tg (ins-GFP) embryos were obtained from Dr. Phillip diIorio at the University of 
Massachusetts Medical School Zebrafish Facility (Worchester, MA).  This strain was 
chosen due to its specific expression of green fluorescent protein in the beta cells of the 
endocrine pancreas. Heterozygous nrf2a
fh318
 embryos, that were crossed to obtain the 
wildtype nrf2a
+/+ 
embryos used in these experiments, were generated by the Tilling 
Mutagenesis Project, obtained from the Moens Laboratory (Fred Hutchinson Cancer 
Research Center, Seattle, WA) and acquired as a generous gift from Dr. Mark Hann of 
the Woods Hole Oceanographic Institute (Woods Hole, MA).  
All zebrafish used in these experiments were maintained under 14 hours of light 
and 10 hours of darkness at 28.5̊C in an Aquaneering system, and adults were fed a diet 
of Gemma Micro granule fish food (Skretting, Westbrook, ME) daily. Embryos were 
collected from group matings of three 6 liter tanks of approximately 20 fish per tank with 
a 1:2 male to female ratio. Embryos were maintained at low densities (approximately 30 
embryos) in 10 mL 0.3x Danieau’s solution (17 mM NaCl, 2 mM KCl, 0.12 mM MgSO4, 
1.8 mM Ca(NO3)2, 1.5 mM HEPES, pH 7.6) (Westfield et al, 2007). Embryo water was 
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changed daily. All procedures are approved by the University of Massachusetts Amherst 
IACUC committee (Animal Welfare Assurance Number A3551-01). 
2.2.3. Survivorship 
Wildtype zebrafish of the AB line, obtained from Boston Children’s Hospital 
(Boston, MA), were used to observe survivorship. Embryos were exposed to 
butylparaben concentrations of 1,000, 3,000 and 5,000 nM butylparaben, suspended in 
0.01% (v/v) Dimethyl Sulfoxide (DMSO). This solvent was selected due to its lack of 
toxicity in animal models. Butylparaben concentrations were chosen after a preliminary 
dose range-finding experiment saw complete mortality following exposure to 10,000 nM 
butylparaben.  
Chemical exposures began at 3 hours post fertilization (hpf) and were replicated 
daily until 72 hpf. This exposure regime was used for two key reasons: 1) the literature 
suggests that parabens are rapidly metabolized, within 24 hours of exposure in rabbit 
models (Soni et al, 2005), and  2) it is assumed that the majority of human paraben 
exposure is due to cosmetic applications, so re-dosing daily will most accurately mimic 
human exposure patterns. 
 Embryos were collected and screened approximately one hour after fertilization 
and were divided into four groups, each group containing 30 embryos. Each group of 30 
embryos was placed in a glass Petri dish containing 20 mL of 0.3x Danieau’s solution 
and 0.01% (v/v) DMSO, 1,000, 3,000 or 5,000 nM butylparaben. Embryos were then 
individually placed into 96-well plates, with 200 µL of their respective dosed water, and 
imaged using Evos FL auto inverted fluorescent microscope (Life Technologies, 
Pittsburgh, PA) to check for fertilization. Exposures and whole-embryo imaging was 
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repeated at 24, 48 and 72 hpf with one trial of approximately 27-30 embryos per 
treatment. Embryos were maintained in 96-well plates throughout the experiment. 
Observations of mortality, heartbeat, yolk sac coagulation, hatching status, and 
pericardial and yolk sac edema were recorded at each time point. 
2.2.4. No Observed Effect Concentration (NOEC)  
In order to determine the no observed effect concentration (NOEC) of 
butylparaben exposure to the pancreatic islet, Tg (ins-GFP) embryos were exposed daily 
to concentrations of 62.5, 125 and 250 nM butylparaben. Embryos were imaged and 
analyzed at 4 days post fertilization. Exposures and imaging were carried out as described 
above. Images were taken at 40x magnification to screen embryos for developmental 
malformations, and at 100x and 200x magnification under trans and GFP overlaid filters 
to image pancreatic islets. Islet areas were measured blindly using EVOS software and 
islet deformities were quantified. This procedure was repeated twice with 10 embryos per 
treatment. 
2.2.5. Chemical Exposures 
In order to expose embryos to a wide range of butylparaben concentrations in 
both imaging and gene expression experiments, embryos were exposed to 0.01% (v/v) 
DMSO or 250, 500, 1,000, or 3,000 nM butylparaben in 20 µL of 0.3x Danieau’s. These 
concentrations were chosen after preliminary data from the survivorship study were 
analyzed due to their low production of morphological abnormalities and low mortality 
rates. Exposures began at 3 hpf and were renewed daily with water changes (0.3x 
Danieau’s solution) until 7 days post fertilization (dpf). Embryos in all experiments were 
manually dechorionated at 1 dpf using watchmaker’s forceps.  
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2.2.6. Microscopy 
 Islets, islet morphology and embryonic developmental morphology were imaged 
in Tg (ins-GFP) embryos at 3, 4, 5 and 7 dpf. Images were obtained with an EVOS Auto-
FL Inverted microscope (Life Technologies, Pittsburgh, PA). At each imaging time point, 
embryos were anesthetized with MS222 (tricaine) in 0.3x Danieau’s solution and then 
placed into individual drops of 3% methylcellulose in a right lateral orientation. Images 
were taken at 20x and 40x magnification under a trans filter, and at 100x and 200x 
magnification under trans and GFP filters using Evos FL auto inverted fluorescent 
microscope (Life Technologies, Pittsburgh, PA). After imaging, all embryos were washed 
in 20 mL of 0.3x Danieau’s, re-dosed with their respective treatment and stored at 
28.5
o
C. 
2.2.7. Imaging Analysis 
All islet images used in islet area analysis were taken at 200x magnification, and 
islet area was measured blindly using EVOS software. Islets that were not in focus or that 
were occluded by pigmentation were excluded (approximately 1-4 embryos per 
concentration per trial). Three categories of islet deformities were observed: islet 
fragmentation (where the beta cells of the islet are more dispersed), ectopic beta cells 
(where a beta cell emerges away from the primary islet), and “fuzzy” islets (whose fuzzy 
appearance is not an artifact of the imaging process). To quantify whether butylparaben 
affected embryonic gross development, yolk sac area (a surrogate measure of the 
embryo’s ability to uptake nutrients) and whole embryo nose-to-tail lengths (to measure 
embryo growth) were measured using EVOS software. Because the swim bladder is 
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derived from the same progenitor endoderm cells as pancreatic beta cells, delayed swim 
bladder inflation was also evaluated (Kimmel and Meyer, 2010). 
A total deformity index was created to quantify the five developmental 
deformities observed with butylparaben exposure. These deformities include: pericardial 
edema (fluid retention in the membrane surrounding the heart), decreased yolk sac 
utilization (increased yolk sac contents), intestinal effusion (fluid retention in the 
intestinal lumen), craniofacial malformations and spinal malformations. Each deformity 
was scored on a scale from 0-3, with 0 as normal, 1 for a mild deformity, 2 for a 
moderate deformity and 3 for a severe deformity. A deformity index was then calculated 
as the sum of scores for each individual embryo in each dose group at each time point 
divided by the maximum score possible, and multiplied by 100. This approach is in 
agreement with other deformity assessments in fish embryo models (Harbeitner et al, 
2013, Wassenberg et al, 2004, and Whitehead et al, 2010).    
2.2.8. RNA Extraction and Reverse Transcription 
Wildtype nrf2a
+/+
embryos (5 biological replicates of approximately 10-12 
embryos per treatment) were exposed daily to DMSO, 250, 500, 1,000 or 3,000 nM 
butylparaben and collected for RNA isolation at 3 days post fertilization. Samples were 
stored at -80ºC in 100 µL RNA Later. Prior to RNA extraction, all materials and surfaces 
were sprayed with RNase Away® (Molecular Bio Products). RNA extractions were 
carried out according to the GeneJET RNA Purification Kit Total RNA Purification 
Protocol (Thermo Fisher Scientific Inc., Waltham, MA). Samples were sonicated for 
approximately one second at 15 % amplification with a Branson Digital Sonifier® 
(Danbury, CT) that was sterilized with 75% ethanol between each sonication. RNA 
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concentration and quality was analyzed using a BioDrop µLITE (BioDrop, Cambridge, 
UK). Reverse transcription to cDNA was carried out according to the manufacturer’s 
protocol using an iScript cDNA synthesis kit for reverse transcription PCR (Bio-Rad 
Laboratories, Hercules, CA) with a final concentration of RNA of 500 ng/ 15 µL RNA. 
Synthesis was then carried out in an Eppendorf Mastercycler® nexus gradient thermal 
cycler (Eppendorf, Hauppague, NY) according to the reaction protocol provided by 
iScript.  
2.2.9. Quantitative real-time PCR 
To gain insight about the function of beta cells, the transcription of genes in the 
pancreatic endocrine hormone axis was measured. Gene expression of the pancreatic 
hormones preproinsulin a (insa), glucagon a (gcga), ghrelin (ghrl), and somatostatin 2 
(sst2) and the transcription factor pancreatic duodenal homeobox 1 (pdx1) were 
quantified with β-actin utilized as a housekeeping gene. β-actin is a known housekeeping 
gene used with the zebrafish model, and its expression has not been shown to change due 
to chemical exposures (McCurley and Callard, 2008).  
All primers were first tested for specificity and efficiency. Primers were designed 
using Primer-BLAST (NCBI) and were optimized for melting temperature and for 
dimerization, to avoid both homodimer and heterodimer dimerization.  cDNA was diluted 
to a working concentration of 0.125 ng/µL, as previously performed by Rousseau et al 
(2015). A 20 µL PCR reaction was carried out that contained 0.5 µL of each foreword 
and reverse primer, 10 µL of 2x iQ™ SYBR® Green Supermix (Bio-Rad), 5 µL of 
nuclease-free water, and 4 µL of diluted cDNA. Quantitative real-time PCR (qPCR) was 
performed in a Bio-Rad CFX Connect™ real-time system under the conditions of 2 
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minutes at 95ºC followed by 10 seconds at 95ºC, and then 25 seconds at 60-68ºC 
depending on the melting temperature of each primer. A dissociative curve was created 
for each primer run. The primer sequences (5’-3’ orientation) used for the pancreas-
related genes gcga, insa, pdx1 and housekeeping gene β-actin are listed in Table 1. The 
primers for sst2, and ghrl were purchased from Bio-Rad (PrimePCR™). Data obtained 
from qPCR were analyzed using the Bio-Rad CFX Connect Manager™ software, version 
3.0 (Bio-Rad). The ddCT method was used to calculate fold change.  
 
Table 1. Primer sequences of pancreas-related genes gcga, insa, pdx1 and housekeeping 
gene β-actin. 
 
Gene 
 
Primer Sequence 5'-3' 
   gcga Foreword GGACAACCCAAACCAGATGTT 
 
Reverse CCTGACGCCTTCGAGTTCAT 
insa Foreword GCCCAACAGGCTTCTTCTACAAC 
 
Reverse GCAGATTTAGGAGGAAGGAAACCC 
pdx1 Foreword CATCTCTACAGTCGCTCGGG 
 
Reverse ACCATATAAGGGCCTGTCCAC 
β-actin Foreword CAACAGAGAGAAGATGACACAGATCA 
 
Reverse GTCACACCATCACCAGAGTCCATCAC 
 
2.2.10. Statistical Analysis  
Data was analyzed using Microsoft Excel and Stata statistical software, version 
14.1. All statistical tests were performed by Stata. Two-factorial ANOVAS followed by a 
Tukey’s post hoc test or a Wald’s post hoc test were used to test for effects among 
exposed groups and controls. Logistic regression analysis was performed to determine 
significance for swim bladder data and a Mann-Whitney U test was used to analyze the 
deformity index. Probit analysis was performed to analyze survivorship. A McNemar’s 
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test for significance was used to determine independence between islet deformities and 
morphological deformities. Data are presented as the mean and the standard error of the 
mean (SEM).  
2.3. Results 
2.3.1. Survivorship 
In order to assess embryonic survivorship in response to daily butylparaben 
exposure, survivorship analysis was performed daily until 3 days post fertilization. The 
control (DMSO) and 1,000 nM groups retained 96% and 92% survivorship throughout all 
time points respectively. Survivorship in the 3,000 nM group decreased from 88% to 
85% survivorship at 3 dpf. Survivorship in the 5,000 nM group decreased from 89% to 
85% over the three day exposure (Figure 5).  
 
Figure 5. Survivorship of wildtype embryos after exposure to 3 different 
concentrations of butylparaben. Thirty embryos per treatment were exposed to 0.01% 
(v/v) DMSO, 1,000, 3,000 or 5,000 nM butylparaben. Survivorship was observed daily 
until 3 days post fertilization. 
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2.3.2. Butylparaben Disturbs Pancreatic Islet Development  
To determine the low-dose toxicity of butylparaben on islet development, the 
NOEC was calculated for islet area and defects. Islet area increased in a dose-dependent 
manner (Figure 6). However, this trend was only significant at the highest concentration 
(250 nM) (p< 0.05). Here, the lowest observed effect level concerning islet area was 250 
nM, and the no observed effect level was 125 nM. Butylparaben also induced islet 
deformities at 250 nM, with 70% of islets displaying a malformation compared to 20% of 
embryos exposed to 125 nM, and 0% of embryos exposed to 62.5 nM and 22 % of the 
controls (Table 2). 
 
Figure 6. Islet areas are sensitive to butylparaben down to concentrations of 250 nM 
at 4 dpf. Transgenic (ins-GFP) embryos were exposed daily to 62.5, 125 and 250 nM 
butylparaben (n= 15-20 embryos per treatment). Imaging was performed at 4 dpf under a 
trans and GFP filter using EVOS imaging software. Islet areas were measured using 
EVOS software editing tools. p<0.05. 
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Table 2. Incidences of total and specific islet deformities in embryos exposed daily to 
DMSO, 62.5, 125, or 250 nM butylparaben at 4 dpf. 
 
Control 62.5 nM 125 nM 250 nM 
Total Defects 3/14 (21%) 1/19 (5%) 4/16 (25%) 9/17 (53%) 
Fragmented 2/14 1/19 1/16 1/17 
Ectopic 1/14 0/19 3/16 5/17 
Fuzzy 0/14 0/19 0/16 3/17 
 
In order to quantify beta cell development, the area of islet fluorescence was 
measured at the time points of 3, 4, 5 and 7 days post fertilization. Butylparaben exposure 
was found to significantly increase islet area by as much as 55%. Islet area increased 
significantly for all concentrations of butylparaben when compared to controls at 3 dpf 
(p< 0.05) (Figure 7). Embryos exposed to 250 nM butylparaben had islet areas that were 
significantly larger than controls at all time points (3, 4, 5 and 7 dpf). At 4 dpf, islet area 
was significantly greater in embryos exposed to 250 and 500 nM butylparaben, and at 5 
dpf only embryos exposed to the lowest concentration of 250 nM saw a significant 
increase in islet area. At 7 dpf, islet area was significantly greater in embryos exposed to 
the lowest (250 nM) and highest (3,000 nM) concentrations of butylparaben (p<0.05) 
(Figure 7).  
Islet area was also seen to increase over time until 5 dpf and then decrease at 7 
dpf. However, exposure to 3,000 nM butylparaben decreased islet area at all time points 
when compared to areas at 3 dpf (Figure 8).  
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Figure 7. Daily exposure to butylparaben increases islet area over 7 days. Transgenic 
ins-GFP zebrafish were exposed daily to 250, 500, 1,000, and 3,000 nM butylparaben 
and imaged under a GFP filter using EVOS Auto-FL Inverted microscope software at 3, 
4, 5 and 7 days post fertilization. Islet areas were measured using the EVOS software 
editing tools (n= 15-25 embryos).  A one-factor ANOVA followed by a Tukey’s post hoc 
test was utilized to test for effects among exposed groups and controls. Means sharing a 
letter in the group label are not significantly different at the 5% level. 
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Figure 8. Islet area decreases over time with butylparaben treatment. Transgenic ins-
GFP zebrafish were exposed daily to 250 nM, 500 nM, 1,000, and 3,000 nM 
butylparaben and imaged under a GFP filter using EVOS Auto-FL Inverted microscope 
software at 3, 4, 5 and 7 days post fertilization. Islet areas were measured using the 
EVOS software editing tools (n= 15-25 embryos). A two-factorial ANOVA followed by 
a Wald post hoc test was used to test for effects among exposed groups and controls (p< 
0.05). 
 
Exposure to butylparaben also resulted in irregular development of the pancreatic 
islet that was observed at 3-7 dpf. The three most prevalent deformities observed were 
fragmentation of the beta cells, where the beta cells of the islet appear more dispersed  
(Figure 9.B.), ectopic beta cells, in which a beta cell emerges away from the primary islet 
(Figure 9.C.) and “fuzzy” islets, where the fuzzy appearance is not an artifact of the 
imaging process (Figure 9.D.). The incidence of these deformities changed with 
butylparaben exposure. Fragmented islets were most prevalent at the 250 nM 
concentration (44%), whereas ectopic beta cells were most prevalent at 500 nM (16%), 
and “Fuzzy Islets” were predominant at 3,000 nM (54%) (Table 3). Between 3 and 7 dpf, 
90% of control embryos displayed normally developed islets compared to 53% of the 250 
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nM group, 75% of the 500 nM group, 71% of the 1,000 nM group, and 67% of embryos 
exposed to 3,000 nM groups. Three day post fertilization embryos that were exposed to 
250 nM and 3,000 nM butylparaben had the greatest incidence of total islet defects (56% 
and 58% respectively) (Table 3). Islet fragmentation decreased over time, whereas the 
prevalence of “Fuzzy Islets” appeared to decrease over time at the higher concentrations 
of 1,000 nM and 3,000 nM, but increased at the lower concentrations of 500 nM and 250 
nM butylparaben (Table 3). There are no obvious trends relating to the incidence of 
ectopic beta cells. It is important to note that these malformations may contribute to 
increased islet size.  
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3 dpf 4 dpf 5 dpf 7 dpf 
 
           
Total 
Defects Control 2/23 (9%) 3/23 (13%) 3/23 (13%) 1/21 (4%) 
  Fragmented 1/23 2/23 1/23 0/23 
  Ectopic 0/23 1/23 2/23 0/21 
  Fuzzy 1/23 0/23 0/23 1/23 
            
Total 
Defects 250 nM 9/16 (56%) 8/16 (50%) 7/16 (44%) 6/16 (38%) 
  Fragmented 7/16 7/16 5/16 4/16 
  Ectopic 1/16 1/16 2/16 0/16 
  Fuzzy 1/16 0/16 0/16 2/16 
            
Total 
Defects 500 nM 8/25 (32%) 4/24 (16%) 5/24 (21%) 7/24 (29%) 
  Fragmented 3/25 2/24 0/24 2/24 
  Ectopic 4/25 2/24 2/24 1/24 
  Fuzzy 1/25 0/24 3/24 4/24 
            
Total 
Defects 1,000 nM 10/25(40%) 9/25 (36%) 4/25 (16%) 6/25 (24%) 
  Fragmented 4/25 5/25 0/25 2/25 
  Ectopic 1/25 3/25 2/25 2/25 
  Fuzzy 5/25 1/25 2/25 2/25 
            
Total 
Defects 3,000 nM 15/26(58%) 11/26 (42%) 6/26 (23%) 2/26 (8%) 
  Fragmented 1/26 0/25 1/25 1/26 
  Ectopic 0/26 1/25 2/25 0/26 
  Fuzzy 14/26 10/25 2/25 1/26 
Table 3. Incidences of specific and total islet deformities: Fragmented, Ectopic and Fuzzy.  
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Figure 9. Examples of islet deformities at 4 dpf. Images were taken at 200x 
magnification after daily exposure to butylparaben in Tg(ins-GFP) embryos. A) Control 
(DMSO) embryos have characteristically spherical islets. B) Fragmentation of the islet. 
C) An ectopic beta cell. D) Islet is fuzzy, focus was not obtainable through the imaging 
process. Images are overlaid Trans and fluorescent GFP images taken at 200x 
magnification. These deformities are observed at 3, 4, 5 and 7 dpf 
 
2.3.3. Developmental Toxicity of Butylparaben 
To determine the effects of butylparaben on embryonic development, embryos 
were analyzed for developmental deformities. Tg (ins-GFP) embryos were exposed daily 
to concentrations of 250, 500, 1,000 and 3,000 nM butylparaben, and were imaged at 3, 
4, 5 and 7 dpf. Five developmental deformities were used in a deformity index: 
pericardial edema, underutilized yolk sac, intestinal effusion, craniofacial malformations 
and spinal malformations (Figure 10.B). Butylparaben increased total deformities in a 
dose-dependent manner. Embryos exposed to the lowest concentration, 250 nM, did not 
show more deformities when compared to the controls at any time point. The highest 
concentration, 3,000 nM, significantly increased total deformities at all time points 
(p<0.0001). Embryos exposed to 500 nM butylparaben only showed more deformities at 
3 and 7 days post fertilization, and those exposed to 1,000 nM saw significantly more 
deformities at 3, 4, and 7 dpf (Figure 10.A). At 3 dpf, butylparaben exposures greater 
than 250 nM significantly increased total deformities when compared to the controls 
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(Figure 10.A.). It is important to note that some embryos displayed multiple deformities.  
However most embryos were not deformed at all, and the majority of embryos that were 
deformed did not have any islet defects. 
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Figure 10. Deformity index for total morphological deformities and examples of 
morphologic deformities. A. Deformity index for total morphologic deformities. 
(Max Deformity Score = 100) Total developmental deformities including pericardial 
edema, underutilized yolk sac, intestinal effusion, craniofacial malformations and spinal 
B. 
32 
 
malformations. Tg(ins-GFP) embryos were exposed to 250, 500, 1,000 and 3,000 nM 
butylparaben daily (5-10 embryos per treatment for 4 trials) and imaged using EVOS 
Imaging software at 40x magnification.  *=p<0.05, **=p<0.0001. B. Examples of 
morphologic deformities. Specific developmental deformities including pericardial 
edema, underutilized yolk sac, intestinal effusion, craniofacial malformations, and spinal 
malformations increase in severity from 1-3 at 3-7 dpf. Images were taken at 40x 
magnification in Tg(ins-GFP) embryos exposed daily to DMSO,  250, 500, 1,000, and 
3,000 nM butylparaben. 
 
          To observe the effects of butylparaben on gross embryonic development, yolk sac 
utilization and embryonic growth were quantified. Embryonic yolk sac areas were 
measured at 3, 4 and 5 dpf to measure nutrient uptake. We found no significant 
relationship between butylparaben concentration and yolk sac area. Although a trend in 
smaller yolk sac area was seen throughout all time points at the 250 nM exposure, this 
trend was not significant (Figure 11.A.). Embryonic growth was quantified by measuring 
nose-to-tail linear length. Similarly to yolk sac area, embryonic body length was not 
significantly affected by butylparaben at any concentration from 3-7 dpf (Figure 11. B.).  
 
 
Figure 11. Gross development is not significantly affected by daily butylparaben 
exposure. Tg(ins-GFP) embryos were treated daily with 250, 500, 1,000 and 3,000 nM 
butylparaben (n=30 embryos per treatment for 4 trials). Yolk sac areas and embryonic 
nose-to-tail lengths were measured to determine embryonic yolk sac utilization and 
embryonic growth at 3, 4, and 5 dpf using EVOS software editing tools. A two factor 
ANOVA was utilized to test for affects among exposed and control groups. 
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In addition to embryonic growth, swimbladder inflation in response to chemical 
exposures is an endpoint that is often observed in the zebrafish model. Because the 
teleost swim bladder is derived from the same progenitor endoderm layer as the pancreas, 
we examined the effect of butylparaben on swim bladder inflation at 4, 5, and 7 days post 
fertilization. Throughout all time points, there was a trend in increased swim bladder 
inflation at 250 nM when compared to controls, though this trend was only significant at 
4 dpf. Swim bladder inflation significantly decreased at the highest concentration (3,000 
nM) by 40%, 62 %, 50% when compared to the controls at 4, 5 and 7 dpf respectively (p 
< 0.05) (Figure 12). The concentrations of 500 and 1,000 nM butylparaben did not affect 
swim bladder inflation when compared to the controls.  
 
Figure 12. Percent swimbladder inflation at 4, 5 and 7 dpf. Tg (ins-GFP) embryos 
were treated daily with 250, 500, 1,000 and 3,000 nM butylparaben (n=30 embryos per 
treatment). Inflated swimbladders were quantified for each treatment. Logistic regression 
was used to determine differences among control and exposed groups (p<0.05). 
 
To further investigate whether these developmental morphologies may be 
contributing to the occurrence of islet deformities, the relationship between the specific 
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morphologic deformities (swimbladder inflation, intestinal effusion, spinal 
malformations, decreased yolk sac utilization, pericardial edema, and craniofacial 
malformations) and islet architecture was observed using a McNemar’s test for 
independence. P-values produced by this test that are greater than 0.05 indicate the 
relationship between the specific morphologic deformity and the occurrence of islet 
deformities occur independently. P-values that are less than 0.05 indicate a lack of 
independence. Here, the relationship between specific morphologic deformities and the 
occurrence of pancreas deformities was measured in control groups and embryos that 
were exposed to 250 and 3,000 nM butylparaben at 4 dpf. No clear relationship was 
observed between the occurrence of developmental deformities and islet architecture 
(Figure 13). However, it is interesting to note that these relationships change based on 
exposure (Figure 13).  
Deformity Controls 250 nM 3,000 nM 
Swimbladder Inflation 0.005 0.054 0.001 
Intestinal Effusion 0.083 0.256 0.124 
Spinal Malformations 0.157 0.005 0.003 
Decreased Yolk Utilization 0.561 0.008 0.739 
Pericardial Edema 0.650 0.005 0.739 
Craniofacial-
malformations 1.000 0.004 0.004 
 
Figure 13. The relationship between morphologic deformities and islet architecture. 
The relationship between specific morphologic deformities and the occurrence of islet 
deformities in control groups and embryos that were exposed to 250 and 3,000 nM 
butylparaben at 4 dpf (n= 30 embryos per treatment). A McNemar’s test for 
independence was performed to investigate whether these relationships are independent. 
2.3.4. Expression of Pancreas-related Genes 
 To assess the effects of butylparaben on beta cell function, the gene expression of 
the pancreatic endocrine hormone axis was measured. Gene expression of the pancreatic 
hormone index: preproinsulin a (insa), glucagon a (gcga), ghrelin (ghrl), and 
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somatostatin 2 (sst2) was measured using a real-time quantitative polymerase chain 
reaction (qPCR). The transcription factor pancreatic duodenal homeobox 1 (pdx1) was 
also measured, and β-actin was utilized as a housekeeping gene. There was no significant 
relationship between butylparaben exposure and the gene expression of the pancreatic 
hormone index. However, the expression of pdx1 was significantly downregulated at the 
highest concentration (3,000 nM) (Figure 14).  
 
Figure 14. Pdx1 is downregulated at the 3,000 nM butylparaben exposure. Wildtype 
embryos were exposed daily to DMSO, 250, 500 or 3,000 nM butylparaben, and were 
collected at 78 hpf. Expression of pdx1 was measured and the ddCt method was used to 
calculate fold change, followed by pairwise T-tests to calculate significance (p< 0.05). 
N= 5 biological replicates per group with each replicate containing pools of 10-13 
embryos. 
2.4. Discussion 
 The endocrine pancreas is highly vascularized and is therefore likely exposed to 
chemicals, such as parabens, that may be in the blood stream. There is great potential for 
human exposure to butylparaben, and it has been recovered in pancreatic tissues and in 
human amniotic fluid at concentrations of 0.3 µg/L. In this study, I hypothesized that 
butylparaben would affect the development of the pancreatic islet. To test this hypothesis, 
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I analyzed whether butylparaben alters the development of the endocrine pancreas while 
observing butylparaben’s effects on gross development in zebrafish embryos.  
The data from this study indicate butylparaben affects islet development by 
increasing islet area and increasing the incidence of islet deformities. The cause of this 
increasing islet area with butylparaben exposure is unclear, however some potential 
explanations include increased islet area due to fragmentation of the islet cluster, 
augmented beta cell proliferation, larger beta cell size due to greater numbers of cell 
vacuoles, amplified beta cell differentiation, and increased islet area due to the increased 
presence of “fuzzy” islets. 
  Embryos that were exposed to the lowest concentration (250 nM butylparaben) 
had islet areas that were significantly larger than controls at all time points analyzed (3, 4, 
5 and 7 dpf). This could be due to the dispersion of the islet cluster into fragmented cells, 
where an average of 36% embryos exposed to the 250 nM concentration had fragmented 
islets over all time points compared to 4% of controls, 7% of embryos exposed to 500 
nM, 11% of embryos exposed to 1,000 nM and 3% of embryos exposed to 3,000 nM 
(Table 3). Another zebrafish study has also found islet dispersion or fragmentation to 
increase islet area, as seen in embryos that were exposed to 5 nM PCB-126 (Timme-
Laragy et al, 2015). Butylparaben-induced cell dispersion has also been shown in rodent 
models. Alam et al (2013) found butylparaben to cause the collapse of rat Sertoli cell 
vimentin filaments, allowing spermatogenic cells to become separated from the Sertoli 
cells and become more dispersed. Butylparaben treatment also increased the size and 
number of Sertoli cell vacuoles in a time and dose-dependent manner (Alam et al, 2013). 
37 
 
Here, an increased number of vacuoles in beta cells could increase beta cell size and 
potentially increase islet area.  
Greater islet area could also be caused by augmented cell differentiation of beta 
cell progenitors. Butylparaben has been found to increase cell differentiation, however 
only in adipocyte cells, demonstrating a limitation of the existing literature.  Hu et al 
(2013) found butylparaben, in the presence of a differentiation cocktail, to increase 
adipocyte differentiation when compared to cells exposed to DMSO. Parabens have also 
been found to enhance adipocyte differentiation with increasing alkyl chain length, with 
butylparaben promoting the most adipocyte differentiation.  Taxvig et al (2012) also 
found butylparaben to promote the differentiation of pre-adipocyte fibroblasts into 
adipocytes.  
 The increased incidence of “fuzzy” islets could also be contributing to the larger 
islet areas observed at the highest concentration (3,000 nM). The cause of this “fuzzy” 
deformity is still unclear. Butylparaben acts through altering cell membrane properties, 
and has been shown to allow intercellular solutes to leak from cells by changing cell 
membrane integrity (Doron et al, 2001 and Furr et al, 1972). It is possible that 
butylparaben may affect the cell membrane integrity of beta cells in a similar way, 
causing them to become “leaky” and to appear fuzzy under the microscope. However, if 
butylparaben were causing the membranes of beta cells to become leaky, it is likely that 
the membranes of other cells may become leaky as well and appear “fuzzy” under a trans 
filter. Therefore, further analysis is needed to determine whether the beta cell membranes 
in these “fuzzy” islets are leaking. Future studies will utilize confocal and histological 
analysis of these fuzzy islets to examine islet architecture.   
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It is also possible that the “fuzzy” islets have not aligned properly during 
development, and have not fully migrated to the right side of the embryo, causing the 
islets to be visually distorted by the yolk sac. Other environmental chemicals such as 
PCB’s have been found to interfere with zebrafish islet migration during development. 
Zebrafish embryos treated with PCB-126 revealed islets that aligned with the third somite 
rather than the fourth somite between 24 and 48 hpf (Timme-Laragy et al, 2015). Future 
studies will image embryos that display fuzzy islets ventrally to view islet position and to 
discover whether butylparaben disrupts islet alignment.  
 Data from this study also indicate that 250 nM is the lowest concentration in 
which butylparaben impacts islet development. In this study, the lower concentrations of 
62.5 nM and 125 nM appeared to increase islet area in a dose-dependent manner 
however, this trend was not significant. As a result, because the lowest concentration in 
which significant pancreatic effects were observed was 250 nM, it is possible that 250 
nM (0.0485 mg/L) butylparaben is the LOEC for islet deformities in zebrafish. The 
lowest concentration in which no significant islet defects occurred was 125 nM, 
suggesting 125 nM may be the concentration in which no effects are observed, or the 
NOEC. When exposed to butylparaben daily for 7 days, fatheaded minnows were found 
to experience a NOEC of 1.0 mg/L butylparaben (Dobbins et al, 2009) and a LOEC of 
2.0 mg/L, or 10,297 nM when looking at embryonic growth as an outcome. This is 
evidence that the pancreas is a more sensitive endpoint in terms of butylparaben 
exposure.   
 To further investigate the disrupted islet development, I measured the gene 
expression of the pancreatic hormone index (insa, gcga, sst2 and ghrl) and the 
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transcription factor pdx1. Exposure to butylparaben only significantly decreased the 
expression of pdx1 at the highest concentration (3,000 nM), however exposure did not 
significantly affect the expression of the pancreatic hormone index. Pdx1 plays a role in 
regulating beta cell function by regulating the expression of insulin. Unlike the hormones 
of the pancreatic hormone index, Pdx1 is redox sensitive, and can be regulated by the 
redox state in cells (Rozenfeld et al, 2012). In vitro, Pdx1 activity has been found to 
decrease with the induction of oxidative stress (Matsuoka et al, 2007). Additionally, Pdx1 
has been found to increase in islets of mice treated with antioxidants N-acetyl cysteine 
(NAC) and Vitamin C (Kaneto et al, 1999). If only oxidative stress were occurring here, 
it would be expected that pdx1 gene expression may be affected. However, if Pdx1 
activity were to be affected as well, it would likely be reflected in the transcriptional 
activity of Pdx1, for example, in the transcription of insulin. Because the expression of 
the pancreatic hormone index does not appear to change in response to the changes pdx1 
expression, it is unclear whether the activity of Pdx1 is affected. Here, the decrease in 
pdx1 expression could be a product of oxidative stress, however it is still unclear whether 
this reduction in pdx1 expression is contributing to the disrupted islet development that 
we are seeing at this concentration. Since Pdx1 transcribes for insulin, it would be 
expected that insulin expression would be downregulated along with pdx1. However, 
here we are seeing no effects on insulin gene expression. It is possible that transcription 
factors upstream of Pdx1 are being affected.  The forkhead/winged helix transcription 
factor (Foxa2) (formerly HNF-3β) is an essential regulator in the development of the 
foregut, that also plays a role in the beta cell-specific transcription of Pdx1 (Wu et al, 
1997). It is possible that butylparaben decreases the activity of Foxa2, which would result 
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in the decreased expression of pdx1. Future studies are needed to observe whether 
butylparaben exposure changes the gene expression of foxa2.  
 The endocrine pancreas can be easily altered by other morphological deformities 
that occur. In this study, embryonic gross development and the incidence of 
morphological deformities were accounted for to determine whether butylparaben affects 
morphological development, and whether these developmental deformities may be 
causing the altered islet development that we are seeing. Yolk sac utilization and 
embryonic growth were measured to determine whether butylparaben affects embryonic 
gross development. In zebrafish embryos, yolk sac area often increases due to an 
accumulation of edema fluid in the yolk sac, and due to a decrease in absorption of yolk 
sac nutrients. The yolk sac is mainly comprised of fatty acids, and free fatty acids have 
been found to regulate the secretion of insulin from beta cells, and have also been found 
to cause beta cell apoptosis in rat islets, providing a mechanism by which obesity can 
lead to the development of type 2 diabetes (Itoh et al, 2003 and Cnop et al, 2001). To 
measure the utilization of nutrients through the yolk sac, embryonic yolk sac areas were 
measured at 3, 4 and 5 dpf. Due to previous studies that suggest exposure to 
environmental chemicals inhibit yolk sac utilization in both mouse and zebrafish embryo 
models, it was originally believed that butylparaben exposure would cause yolk sac areas 
to increase. DEHP, which is similar to butylparaben because it also activates PPARγ, was 
seen to significantly inhibit yolk sac utilization in mice in a dose-dependent manner (Sant 
et al, 2016). Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) significantly 
increased yolk sac area in exposed zebrafish embryos at 120 hpf (Prasch et al, 2003). 
Similarly, increasing copper concentrations resulted in significantly larger yolk sacs in 
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zebrafish embryos at 72 hpf (Johnson et al, 2007). Because no significant trend 
concerning the effects of butylparaben on yolk sac area was observed, it appears that 
butylparaben does not significantly affect the utilization of nutrients at the concentrations 
tested.  
Embryo nose-to-tail length was also used as a measurement of gross development. 
In this study, body length was not significantly affected by butylparaben at any 
concentration at any time point measured. This may be because the concentrations tested 
are too low to affect embryo length. When observing the effects of PFOS on zebrafish 
body length, Shi et al (2008) found that the lower concentrations of 0.1, 0.5 and 1 mg/L 
PFOS did not significantly affect embryo length at 84 and 96 hpf, however, PFOS 
significantly inhibited larval growth when exposed to 3 and 5 mg/mL PFOS. As stated 
above, Dobbins et al (2009), found the LOEC for butylparaben on fat headed minnow 
growth to be much greater than the concentrations that are tested here (10,297 nM vs. 
3,000 nM), suggesting embryonic growth is less sensitive to butylparaben exposure, and 
the concentrations used in the current experiment are too low to see a significant effect.  
The incidence and severity of all deformities were also accounted for in a 
deformity index. Some morphologic deformities occurred with butylparaben exposure, 
however most embryos did not have any deformities, and no relationship was observed 
between developmental deformities and islet architecture, suggesting the pancreas might 
be a sensitive target tissue of butylparaben. The first exposure assessment of the 
developmental toxicity of butylparaben in rats found no significant effects on fetal gross 
development, soft tissue alterations or skeletal alterations at all oral doses tested, with a 
maximum concentration of 1,000 mg/kg/day (Daston et al, 2004). However, to date, no 
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studies have been found to exist that account for or quantify the incidence of 
morphological deformities in response to butylparaben exposure in a fish model. The five 
deformity outcomes observed in this study are all endpoints that are commonly disrupted 
by many toxicants in the zebrafish model. Here,  the greatest incidence of deformities is 
seen at the highest concentrations at all time points, however there was no relationship 
between the occurrence of these deformities and disrupted islet development. 
Additionally, the lowest concentration (250 nM) did not result in a greater incidence of 
morphologic deformities when compared to the controls, but did result in significantly 
greater islet areas and an increased incidence of islet deformities, demonstrating the 
altered islet development that we are observing is occurring independently of 
butylparaben-induced deformities, and that the islet might be a sensitive target tissue of 
butylparaben exposure during development.  
There was also no clear trend in the occurrence of specific developmental 
deformities and deviant islet morphologies. When looking at control, 250 and 3,000 nM 
treatments, the relationships between specific developmental deformities and islet 
architecture change based on exposure. For example, pericardial edema appeared to occur 
independently of islet deformities in the control and 3,000 nM treatment groups (p= 
0.650 and p= 0.739 respectively); however there was a lack of independence in this 
relationship in the 250 nM treatment group (p= 0.005) (Figure 13).  This could be a result 
of the different islet deformities that are prevalent at these two different concentrations: 
fragmented islets at 250 nM and fuzzy islets at 3,000 nM.   
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The time of swimbladder inflation is an endpoint that is commonly disrupted by 
toxicants in zebrafish. Here, the highest concentration of butylparaben (3,000 nM) 
significantly reduced swim bladder inflation at 4, 5 and 7 days post fertilization. 
Exposures to environmental chemicals, such as PCBs have been shown to reduce percent 
swim bladder inflation. Jonsson et al (2012) saw a concentration-dependent reduction in 
the number of individual zebrafish embryos that exhibited inflated swimbladders at 4 
days post fertilization when exposed to 2 nM PCB 126. The swimbladder is derived from 
the same endoderm germ layer as the liver, pancreas and the gut. Because the swim 
bladder and the intestine are both affected by butylparaben, it may be possible that 
butylparaben affects the developing endoderm. Some toxicants, such as TCDD, have 
been found to alter both the pancreas and the liver similarly by causing degradation and 
necrosis of both organs, which may be due to the endodermal origins of both organs 
(Henry et al, 1997 and McCollum et al, 2011). It is also interesting that the transcription 
factor for Pdx1 (Foxa2) regulates the development of the foregut that is also derived from 
the endoderm, and we are seeing a change in the expression of Pdx1 and not in the 
pancreatic hormone index. This could further support the hypothesis that butylparaben 
affects the development of the endoderm. Although no apparent liver malformations were 
observed in this study, because the liver was not an endpoint that was specifically looked 
at, defects may not be detectible by the imaging methods used.  
One way to test for this may be to observe the expression of genes that are 
required for correct endodermal development such as sox32 (which transcribes for the 
transcription factor Sox 32 that has been known to inhibit endodermal formation when 
phosphorylated), sqt, cyc and oep (where mutations in these genes have been found to 
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lead to failures in endodermal development) as reviewed by Ober et al (2003). 
Butylparaben’s effects on endodermal development may also be observed using a Tg(gut-
GFP) zebrafish line, in which green fluorescent protein expression is restricted to the 
endoderm and the organs that it gives rise to. This transgenic line has been used to study 
both endodermal and pancreatic development (Field et al, 2003).  
It is important to note that all butylparaben concentrations used in these 
experiments aim to represent low-dose and environmentally relevant exposures. Although 
the exact concentrations of human exposure to butylparaben are still unknown, one study 
estimates that human exposures due to long-term cosmetic use in the United States ranges 
from 0.26-14.6 mg/day (Masten et al, 2005) (Table 4). Multiple studies have observed 
post-exposure concentrations of un-metabolized butylparaben in human urine (0.2-1,240 
µg/L), blood (135 µg/L) and amniotic fluid (0.3 µg/L) (Table 4). Because the majority of 
butylparaben is metabolized upon exposure, it is likely that these concentrations are 
lower than the actual human exposures. In these studies, zebrafish embryos were exposed 
to butylparaben concentrations that range from 48.5-582.66 µg/L (250-3,000 nM), and 
because these concentrations are within the ranges found in human samples, it is likely 
that the concentrations used in these studies are much lower than those of human 
exposure.  
Table 4.  A comparison of pre and post-metabolism butylparaben concentrations 
in humans and in the concentrations used in these studies.  
    
 
Pre-metabolism Exposure Post-metabolism measure 
 
Humans 260 – 14,600 µg/day Urine:                   0.2-1,240 µg/L (Calafat et al, 2010) 
 
 (Masten, et al 2005) Blood:                             135 µg/L (Janjua et al, 2007) 
   Amniotic Fluid:              0.3 µg/L (Philippat et al, 2013) 
Zebrafish 48.5-582.6 µg/L ? 
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Although all methods in this study have been performed successfully, there are 
limitations to some of the methods. Islets are often occluded by pigmentation at 3 and 4 
dpf, which can make it difficult to obtain a clear view of the islet while imaging. Islets 
are also often imaged through the yolk sac until 5 dpf and can therefore also become 
distorted by the yolk sac contents. An alternative method that could be used to assess 
whether butylparaben affects islet development is flow cytometric analysis. Flow 
cytometric analysis has been performed to count green fluorescent protein labeled beta 
cells from mouse islets (Hara et al, 2003). Flow cytometry would count the exact number 
of beta cells in the pancreatic islets, and also observe if exposure to butylparaben is 
increasing or decreasing islet area due to changes in the numbers of beta cells. Imaging 
with a confocal microscope would also allow for a three-dimensional image of the islet to 
be obtained, allowing for more accurate measurements of islet areas.  
This study demonstrates the effects of butylparaben on the development of the 
pancreatic islet as indicated by an increase in islet area and the incidence of islet 
deformities. Butylparaben does not however appear to affect embryonic morphologic 
growth, and there was no association between the incidence in morphologic deformities 
and islet architecture, suggesting the pancreatic islet may be specifically targeted by 
butylparaben. However, it is still unclear whether any of these developmental effects 
translate to functional consequences, and future studies are needed to characterize the 
long-term effects of these exposures. 
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CHAPTER 3 
BUTYLPARABEN DISRUPTS REDOX BALANCE IN THE DEVELOPING 
EMBRYO 
3.1. Introduction 
 Embryonic development is extremely sensitive to oxidative stress due to changes 
in cell proliferation, development and differentiation that take place during this life stage. 
Reactive oxygen species (ROS) play an important role in normal embryonic development 
by orchestrating cell signal transduction, cell-fate decisions and apoptosis (Ufer et al, 
2010). Embryonic exposure to environmental chemicals, such as parabens, can generate 
ROS and cause disruptions in cellular redox status (Hansen et al, 2006). Embryonic 
oxidative stress can lead to carcinogenesis, cardiovascular dysfunction, pulmonary 
diseases, neurodegenerative diseases and diabetes (Wells et al, 2009). Consequently, 
antioxidant functions that defend against oxidative stress during embryonic development 
are essential.  
The most abundant endogenous antioxidant is glutathione (GSH), a tripeptide that 
consists of glutamate, cysteine, and glycine. GSH acts as an antioxidant by scavenging 
ROS that oxidize the thiol group of the cysteine residue. When GSH is oxidized, it can 
dimerize to form glutathione disulfide (GSSG), which can then be recycled back into 
GSH by the enzyme glutathione disulfide reductase (Gsr), in a reaction that requires 
NADPH (Hansen et al, 2006). The synthesis of GSH involves two ATP-dependent 
enzymatic steps. In the rate-limiting first step, glutamate-cysteine ligase (Gcl) catalyzes 
the combination of glutamate and cysteine, and next glutathione synthetase (Gss) adds 
glycine to the glutamate-cysteine molecule (Timme-Laragy et al, 2013).  
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Butylparaben exposure has been found to be linked to the occurrence of oxidative 
stress in rodent models (Shah et al, 2012 and Hegazy et al, 2015), and has been 
associated with biomarkers of oxidative stress in humans (Kang et al, 2013 and Watkins 
et al, 2015). This study aims to analyze whether daily exposure to butylparaben results in 
the occurrence of oxidative stress. Studies measured the redox potentials of GSH and 
Cysteine, along with total GSH and total Cysteine. Gene expression was also conducted 
on the enzymes that are responsible for GSH synthesis (Gclc, Gclm and Gss), and on the 
enzyme responsible for recycling oxidized GSSG back into reduced GSH (Gsr). The 
expression of two GST enzymes (Gstp and Gsta1) was also measured. These studies aim 
to determine whether exposure to butylparaben affects glutathione redox dynamics, and 
whether it can be associated with the occurrence of oxidative stress in the developing 
zebrafish embryo. 
3.2. Materials and Methods 
3.2.1. Zebrafish Husbandry  
Tg (ins-GFP) embryos were obtained from Dr. Phillip diIorio at the University of 
Massachusetts Medical School zebrafish facility (Worchester, MA), and the heterozygous 
nrf2a
fh318
 embryos were crossed to obtain the wildtype nrf2a
+/+ 
 used in the gene 
expression experiments. This genetic line was generated by the Tilling Mutagenesis 
Project, obtained from the Moens Laboratory (Fred Hutchinson Cancer Research Center, 
Seattle, WA) and was acquired as a generous gift from Dr. Mark Hann of the Woods 
Hole Oceanographic Institute (Woods Hole, MA). All zebrafish were maintained as 
described above in chapter 2.2.2.  
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3.2.2. HPLC Analysis of Soluble Thiols 
Embryos were collected from group matings in three 6 liter tanks of an 
approximate 1:2 male to female ratio. Embryos were stored at 28.5 ºC and maintained at 
low densities (30 embryos per 10 mL) in 0.3x Danieau’s solution and were exposed daily 
to 0.01% (v/v) DMSO, 500 or 1,000 nM butylparaben. Embryos were collected at 24 hpf, 
or re-exposed to butylparaben at 24 hpf and collected at 28 hpf. All embryos were placed 
in 5% PCA buffer and samples were then immediately stored at -80
o
C. Approximately 60 
embryos were used in each treatment.  
GSH, Cysteine, GSSG, Cystine, total GSH, total cysteine and the GSH and 
cysteine redox potentials (Eh) were measured at the University of Michigan, Ann Arbor, 
Michigan by Dr. Karilyn E. Sant using High-performance Liquid Chromatography 
(HPLC). As described by Sant et al (2016) a Waters 2695 Allicance Separations module 
with a Supelcosi LC-NH2 column was paired with at Waters 2475 Fluorescense Detector 
(Sigma, St. Louis MO). Reverse phase chromatography measured GSH, GSSG, cysteine 
and cystine. The flow was set to 1 mL/min using mobile phase A (80% methanol) and 
mobile phase B (62.5% methanol, 12.5 glacial acetic acid and 214 mg/mL sodium acetate 
tryhydrate). Fluorescent detection (excitation 335 nm, emission 518 nm) allowed peaks to 
be visualized, which were then processed with a Waters Empower software (Milford, 
MA).  The Nernst equation VEq=(RT/zF)ln([Xout]/[Xin]) was used to calculate the GSH 
and Cysteine redox potentials. 
3.2.3. Quantitative real-time PCR 
 The expression of glutathione-related genes: the catalytic and modifier subunits of 
Gcl (gclc and gclm), glutathione synthetase (gss), glutathione disulfide reductase (gsr), 
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and two glutathione-s-transferase enzymes (gstp1 and gsta1) were measured using 
quantitative real-time PCR with  RNA extraction and reverse transcription, which were 
performed as described previously in chapter 2.2.8. All primers were first tested for 
specificity and efficiency. Primers were designed using Primer-BLAST (NCBI) and were 
optimized for melting temperature and for dimerization, to avoid both homodimer and 
heterodimer dimerization. Quantitative real-time PCR was also performed as described in 
chapter 2.2.9, with β-actin utilized as a housekeeping gene. The primer sequences (5’-3’ 
orientation) used for the genes gclc, gstp, gsta1 and housekeeping gene β-actin are listed 
in Table 5. Primers for gclm, gss, and gsr were purchased from Bio-Rad (PrimePCR™). 
Data obtained from qPCR were analyzed using the Bio-Rad CFX Connect Manager™ 
software, version 3.0 (Bio-Rad). The ddCT method was used to calculate fold change. 
Table 5. Primer sequences of glutathione-related genes gclc, gstp, gsta1 and 
housekeeping gene β-actin. 
 
Gene 
 
Primer Sequence 5'-3' 
   gclc Foreword AACCGACACCCAAGATTCAGCACT 
 
Reverse CCATCATCCTCTGGAAACACCTCC 
gstp Foreword CGACTTGAAAGCCACCTGTGTC 
 
Reverse CTGTCGTTTTTGCCATATGCAGC 
gsta1 Foreword TCACACCTGCCGAAAACAAAG 
 
Reverse CCACGAGGAAAGAAGAGTTTGC 
β-actin Foreword CAACAGAGAGAAGATGACACAGATCA 
 
Reverse GTCACACCATCACCAGAGTCCATCAC 
 
3.3.4. Statistical Analysis 
Data was analyzed using Microsoft Excel and Stata statistical software, version 
14.1. All statistical tests were performed by Stata. Two-factorial ANOVAS followed by a 
Tukey’s post hoc test or a pairwise t-test were used to test for effects among exposed 
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groups and controls.  Data are presented as mean and the standard error of the mean 
(SEM).  
3.3 Results 
3.3.1. Analysis of Glutathione and Cysteine Redox Potentials 
To analyze redox status in the embryos, GSH, Cysteine, GSSG, Cystine, total 
GSH, total cysteine and the GSH and cysteine redox potentials (Eh) were measured using 
High-performance Liquid Chromatography (HPLC), with the Nernst equation used to 
calculate the GSH and Cysteine redox potentials. There were no significant changes in 
the redox status of embryos that were exposed to butylparaben at 3 hpf and were 
collected at 24 hpf (Figure 15.B). However, significant changes in redox status were 
observed in embryos that were exposed to butylparaben at 3 and 24 hpf and collected at 
28 hpf. Butylparaben concentrations of 500 and 1,000 nM increased GSH by 10% and 
40%, respectively, and decreased GSSG by 37% and 59%. GSH redox potentials became 
more reduced with 500 nM and 1,000 nM butylparaben exposures, decreasing redox 
potentials by 7 and 18 mV, respectively. Cysteine redox potentials also became more 
reduced, decreasing by 17 and 28 mV (Figure 15.A.). Total GSH and total cysteine did 
not significantly change with increasing concentration. 
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Figure 15. Redox analysis of glutathione and cysteine at 28 hpf and 24 hpf. A. Redox 
analysis of glutathione and cysteine at 28 hpf.  Embryonic reduced and oxidized 
glutathione (GSH, GSSG) and cysteine were quantified at 28 hpf after exposure to 
DMSO, 500 nM or 1,000 nM butylparaben at 3 hpf and 24 hpf. The Nernst equation was 
used to calculate cellular redox potentials (Eh). Two factor ANOVAS were used to 
determine differences between exposed and control groups followed by a Tukey’s post 
hoc test (p<0.05, n= 3 samples of 20 pooled embryos). B. Redox analysis of glutathione 
and cysteine at 24 hpf.  Embryonic reduced and oxidized glutathione (GSH, GSSG) and 
A. B. 
C. D. 
E. F. 
G. H. 
B. 
53 
 
cysteine were quantified at 24 hpf after exposure to DMSO, 500 nM or 1,000 nM 
butylparaben at 3 hpf. The Nernst equation was used to calculate cellular redox potentials 
(Eh). Two factor ANOVAS were used to determine differences between exposed and 
control groups followed by a Tukey’s post hoc test (p<0.05, n= 1-3 samples of 20 pooled 
embryos). 
 
Figure 16. Gene expression of glutathione-related genes. Wildtype embryos were 
exposed daily to DMSO, 250, 500 or 3,000 nM butylparaben, and were collected at 78 
hpf. Expression of gsta1, gclc, gss and gsr was measured and the ddCt method was used 
to calculate fold change, followed by pairwise t-tests to calculate significance (p< 0.05). 
N= 5 biological replicates per group with each replicate containing pools of 10-13 
embryos. 
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3.3.2. Expression of Glutathione-related Genes 
The expression of glutathione-related genes was also measured to indicate the 
occurrence of oxidative stress. Gene expression of enzymes that are involved in 
glutathione synthesis: genes encoding for the two subunits of glutamate-cysteine ligase 
(gclc and gclm) and glutathione synthase (gss) were measured in addition to glutathione 
disulfide reductase (gsr), that recycles oxidized glutathione (GSSG) back into reduced 
glutathione (GSH). The expressions of two genes that encode for glutathione-S-
transferases (gstp and gsta1) were also measured. No significant relationship was found 
between butylparaben exposure and the expression of gclm. However, gclc, gss and gsta1 
were all significantly downregulated at the highest concentration (3,000 nM) whereas gsr 
was significantly upregulated at all concentrations in a dose-dependent manner (Figure 
16). The expression of gstp was upregulated at the 500 nM concentration (Figure 16).  
3.4. Discussion 
 Oxidative stress occurs when there is an increase in reactive oxygen species 
(ROS) and insufficient antioxidant defenses, which often leads to toxic effects such as 
damage to lipids, proteins and nucleic acids, contributing to many diseases, including 
diabetes. Antioxidants such as glutathione (GSH) and cysteine defend against oxidative 
stress by scavenging ROS. However, reactive oxygen species do play important roles in 
embryonic development. The redox status, or the ratio of oxidized to reduced 
antioxidants, plays a major role in cell signaling and cell fate decisions. More oxidized 
redox states often signal cell apoptosis whereas more reduced states lead to cell 
proliferation.  
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 In this study, the redox potentials of the thiol-containing redox couples 
glutathione and cysteine were measured in response to butylparaben exposure in 24 hpf 
and 28 hpf zebrafish embryos. Significant changes in redox status were only seen in 
embryos that underwent an acute exposure before collection (exposed at 24 hpf and 
collected at 28 hpf). Embryos that were exposed to butylparaben 4 hours before 
collection saw significant changes in both glutathione and cysteine redox potentials  
(Figure 15.A.), whereas embryos that were exposed 24 hours before collection saw no 
significant changes (Figure 15.B).  
Cysteine is regulated independently of GSH and sits at a more reduced state 
(Jones et al, 2006).  If butylparaben were to cause oxidative stress, it would be expected 
that the GSH and cysteine redox potentials would become more oxidized with increasing 
butylparaben concentration. However, in this study, reduced glutathione (GSH) and 
cysteine increased with increasing butylparaben concentration, while oxidized 
glutathione (GSSG) and cystine decreased with increasing concentration, resulting in a 
more reduced redox state (Figure 1).  
These results contrast somewhat with what has been reported in the literature. 
Shah et al (2012) found butylparaben decreased GSH by 43.8% in the liver tissues of rats 
that were given 1,320 mg/kg bw/day butylparaben. Hegazy et al (2015) treated rat dams 
orally and subcutaneously with 200 mg/kg bw/day butylparaben and measured GSH 
dynamics in the brain tissues of the developmentally exposed offspring. Both oral and 
subcutaneous butylparaben treatments were found to significantly decrease GSH and the 
GSH/GSSG percent ratio, and to significantly increase GSSG and percent oxidized 
glutathione, suggesting oxidative stress occurrence in the brain tissues of the offspring. 
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 None of these studies however observe the effects of butylparaben in the 
developing zebrafish model, and butylparaben concentrations used in the animal studies 
described above are much higher than the concentrations used in the current study. 
Therefore, it is possible that butylparaben causes reductive conditions in the developing 
zebrafish, or at lower concentrations, and results in oxidized conditions in mammalian 
models or at higher concentrations; or it is possible that we are capturing a rebound 
effect. The animal studies that investigate butylparaben and oxidative stress parameters 
also only examine specific organs such as liver and brain tissues, whereas this study 
analyzes the entire embryo. Therefore, it is possible that butylparaben exposure results in 
oxidized conditions in some organs, and reductive conditions in others.  
When reductive conditions are detrimental, they are often referred to as “reductive 
stress.” Reductive stress is defined as “an abnormal increase in reducing elements” such 
as an increased ratio of reduced to oxidized glutathione (Zhang et al, 2010). Reductive 
stress may alter cell proliferation and has been found to delay protein folding in yeast, 
and can lead to protein aggregation, resulting in cardiomyopathy in mice (Simons et al, 
1995 and Zhang et al, 2010). Because the redox results in this study show increased 
ratios of reduced to oxidized glutathione and cysteine, it is possible that reductive stress 
is occurring here. However, due to the studies that show that butylparaben causes 
oxidative stress, it is also possible that the embryos are able to recover and upregulate 
antioxidant defenses, in which case we may be missing the window where oxidative 
stress occurs. When oxidative stress first occurs due to an accumulation of ROS, 
antioxidant defenses are initially slightly depleted and are then turned on in an adaptive 
response. As ROS continue to accumulate, antioxidant defenses become depleted and fall 
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below baseline in a toxic response (Figure 17). In these studies, increasing GSH with 
decreasing GSSG along with the decreased expression of GSH-related genes may 
indicate that redox and gene expression were analyzed when embryos were undergoing 
an adaptive response.   
 
 
 
Figure 17. Increasing levels of reduced glutathione may indicate the occurrence of 
an adaptive response. 
 
In order to further explore whether oxidative stress occurs with butylparaben 
exposure, the expression of genes that are involved in the synthesis of glutathione were 
measured. Glutathione is a tripeptide that is synthesized via two ATP-dependent steps. 
The first step is rate-limiting and occurs when the enzyme glutamate–cysteine ligase 
(Gcl) combines a glutamate and cysteine molecule. Gcl is composed of a catalytic subunit 
(Gclc) and a modifier subunit (Gclm) that is responsible for controlling the rate of GSH 
synthesis, and the expression of both subunits have been shown to increase or decrease in 
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response to reactive oxygen species (Timme-Laragy et al, 2013, Huang et al, 1993 and 
Dickinson et al, 2004). Gclc is responsible for the catalytic activity of Gcl and can be 
directly inhibited by GSH, whereas Gclm does not possess any catalytic function but 
regulates the activity of Gclc (Dickinson et al, 2004).  Oxidative stress is known to 
enhance Gcl activity and increase Gcl expression (Franklin et al, 2009). Therefore, if 
oxidative stress were to occur, the expression of gclc and gclm would be expected to 
increase. The gene expression of both gclc and gclm were measured and showed that only 
the expression of gclc was affected by butylparaben exposure. Embryos exposed to the 
highest butylparaben concentration (3,000 nM) had significantly decreased expression of 
gclc when compared to controls.  
During the second step of GSH synthesis, the enzyme glutathione synthase (Gss) 
adds a glycine to the glutamate-cysteine molecule. We also measured the expression of 
gss and found that its expression was concordant with the expression of gclc, and was 
also significantly downregulated with exposure to 3,000 nM butylparaben. The decreased 
expression of both gclc and gss suggest decreased activity of both the Gcl and Gss 
enzymes. The decreased activity of both Gcl and Gss would likely result in less GSH 
synthesis. Piao et al (2011) found that exposure to silver nanoparticles inhibited the 
activity of Gclc and Gss in human liver cells, leading to decreased GSH levels and an 
increase in ROS. However, because total glutathione was not significantly affected by 
butylparaben exposure, this decreased expression cannot be directly translated to 
decreased Gcl and Gss enzymatic function. Here, it is unclear whether the reduced 
expression of gclc and gss indicate the occurrence of oxidative stress.  
59 
 
To further investigate whether butylparaben causes oxidative stress in the 
developing zebrafish, the expression of glutathione disulfide reductase (Gsr) was also 
measured, which is responsible for recycling oxidized GSSG back into reduced GSH in a 
NADPH-dependent reaction essential for maintaining GHS levels. We found that the 
expression of gsr significantly increased at all concentrations analyzed (250, 500 and 
3,000 nM). Redox analysis also showed that GSSG decreased with increasing GSH in a 
dose-dependent manner. Because gsr expression was upregulated at concentrations that 
were also analyzed for redox status, it is possible that Gsr enzymatic activity is also 
increasing. Increased Gsr activity would recycle greater amounts of GSSG back into 
GSH, possibly resulting in less GSSG and more GSH. This increase in Gsr activity may 
be causing the increased levels of reduced GSH and decreased levels GSSG that are seen 
in the redox analysis data. These results also further suggest a reduced environment with 
butylparaben exposure, and because gene expression was measured two days after redox 
potentials were measured, it appears these reductive effects are lasting. 
In contrast to our findings, Shah et al (2011) found butylparaben exposure to 
decrease Gsr levels and Gsr activity in a dose-dependent manner in liver tissues of mice, 
indicating the occurrence of oxidative stress. The concentrations used by Shah et al 
however were much greater than the concentrations used in this study, ranging from 
13.33 to 40 mg/0.2mL olive oil/kg bw/day. Therefore, the concentrations used in our 
study may not be great enough to decrease Gsr activity or affect its expression. 
Additionally, experiments by Shah et al were carried out in mice, which are a different 
animal model than the zebrafish model used here, and only the liver tissues of these mice 
were analyzed whereas our study analyzes whole embryos. It is possible that Gsr activity 
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increases in the liver but decreases in other tissues, an outcome that may be occluded in 
our experiments. Experiments performed by Shah et al also analyzed Gsr concentrations 
and activity whereas here, only the gene expression of gsr was measured. Because of 
these differences it is difficult to compare these two studies.  
The mechanism that is causing the upregulation of gsr is still unclear. Unlike the 
enzymes that are involved in GSH synthesis, Gsr requires NADPH to recycle GSSG back 
into GSH; therefore it is possible that exposure to butylparaben results in the upregulation 
of NADPH. The activity of Gsr can be monitored by NADPH consumption, and because 
NADPH fluoresces at excitation/emission wavelengths of 340/460 nm (Smith et al, 
1988), future studies could analyze whole-embryo NADPH concentrations by measuring 
its fluorescence. The pentos phosphate pathway is a major source of NADPH and is a 
major source of reducing agents (such as NADPH) for biosynthetic processes and 
maintaining redox potentials to protect against oxidative stress (Juhnke et al, 1996). 
Therefore it is possible that this pathway is affected by butylparaben exposure, and is 
resulting in increased levels of NADPH.  
In addition to NADPH, Gsr also requires flavin adenine dinucleotide (FAD) as a 
redox cofactor for its activity. FAD has been seen to stimulate Gsr activity in vitro, and 
small amounts of 1 µM FAD can activate Gsr within 10 min (Beutler et al, 1969). 
Because Gsr is especially sensitive to FAD, it is also possible that exposure to 
butylparaben up-regulates or increases FAD in the embryos.  
Glutathione also defends against oxidative stress by acting as a cofactor for the 
family of enzymes: glutathione-S-transferases (GSTs). This enzyme family is responsible 
for the detoxification of many xenobiotics by conjugation to GSH. The conjugated 
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xenobiotic metabolites are often more hydrophilic than their unconjugated parent 
molecules, and therefore more easily excreted from cells, making them less toxic (Garner 
et al, 2012). Three classes of GST enzymes (Alpha, Pi and Mu classes), and 19 GST 
genes that are responsible for metabolizing xenobiotics, have been identified in the 
zebrafish model (Timme-Laragy et al, 2013).  Here, gene expression was analyzed for 
gsta1 and gstp1. Similar to the expression of gclc and gss, gsta1 was significantly 
downregulated at the 3,000 nM concentration. However, gstp1 was significantly 
upregulated at the 500 nM concentration. Shah et al (2011) also found butylparaben 
exposure to significantly reduce GST activity in the liver tissues of exposed mice, 
suggesting that this reduction in activities of these enzymes may be due to butylparaben-
induced protein oxidation. Because butylparaben was also found to cause lipid 
peroxidation, the products of lipid peroxidation with these enzymes could modify their 
histidine residues, generating protein-protein crosslinked products, reducing their 
enzymatic activities (Shah et al, 2011). In this study, the downregulation of Gsta1 is 
congruent with the gene expression results and with the redox results that are described 
above, suggesting butylparaben exposure results in a more reduced state. However, the 
upregulation of Gstp1 suggests a more oxidized state.  
This study suggests butylparaben exposure results in a more reduced redox state 
in the developing zebrafish. Gene expression of enzymes involved in glutathione 
synthesis, the catalytic subunit of Gcl (gclc) and gss were significantly downregulated at 
the highest concentration. However, total glutathione was not significantly affected. This 
could be because the expression of gclc and gss is downregulated, but the enzymatic 
functions are not being affected. Additionally, redox analysis was not performed in 
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embryos that were exposed to the highest concentration (3,000 nM butylparaben). The 
expression of gsr, that recycles GSSG back into reduced glutathione (GSH), was 
significantly increased at all concentrations, and these concentrations were also analyzed 
for redox analysis. Redox data showed that GSSG decreased while GSH increased in a 
dose-dependent manner. This could be due to the increased expression of gsr, suggesting 
the enzymatic activity of Gsr is increasing with butylparaben exposure. Therefore, it 
cannot be concluded whether GSH synthesis is affected by these concentrations of 
butylparaben, however, it appears that butylparaben exposure results in a more reduced 
redox state. These results do contradict other studies that show butylparaben causes 
oxidative stress, though none of these studies use the zebrafish model, and the 
concentrations used in other animal studies are much higher than those used in this study. 
Although it is still unclear whether exposure to butylparaben causes reductive or 
oxidative stress, the data from this study indicate that exposure to butylparaben perturbs 
the redox status in the developing embryo. Future studies need to be conducted to further 
determine whether butylparaben causes oxidative stress in the developing zebrafish.  
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CHAPTER 4 
CONCLUSIONS 
 
 These studies reveal that embryonic exposures to butylparaben affect pancreatic 
development in the zebrafish model, however, there is not enough evidence to conclude 
whether oxidative stress is involved. Exposure to butylparaben results in increased islet 
area, and an increased incidence in islet deformities while not significantly affecting 
embryonic gross development. There is also no apparent association between 
morphological deformities and islet architecture, suggesting the islet may be especially 
sensitive to butylparaben as noted earlier. Butylparaben also appears to create a more 
reduced redox environment. Reduced GSH and cystine increase with decreasing oxidized 
GSSG and cysteine in a dose-dependent manner, and both glutathione and cystine redox 
potentials become more reduced with increasing concentration. This could indicate 
increased enzymatic activity of Gsr, that is responsible for recycling GSSG back into 
GSH. The gene expression of the enzymes involved in the synthesis of glutathione (gclc 
and gss) are significantly downregulated at the highest concentration, however total 
glutathione is not significantly affected by butylparaben, suggesting the activity of these 
enzymes may not be changed. The increasing reduced glutathione with increasing 
butylparaben concentration, along with the down-regulation of glutathione-related genes 
may indicate that embryos were analyzed while undergoing an adaptive response to 
oxidative stress.  
 It is still unclear whether oxidative stress is the mechanism that is driving the 
development of these deviant islet morphologies, and it is possible that another 
mechanism is contributing to this such as PPARγ activation. Butylparaben has been seen 
to activate PPARγ, resulting in increased adipocyte differentiation. Although it is unclear 
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what is contributing to the increased islet areas observed in these studies, PPARγ-
activated beta cell differentiation may potentially play a role.  
To further investigate whether butylparaben induces oxidative or reductive stress, 
and whether this stress may impact the developing islet, future studies will analyze 
pancreas development with antioxidant N-acetylcysteine (NAC) and pro-oxidant tert-
butyl hydroperoxide co-treatments. RNA sequencing also needs to be performed in order 
to determine whether other oxidative stress related genes are being affected along with 
other genes that are involved in pancreatic development. 
 It is still unclear whether these islet deformities will develop into functional 
consequences, or if embryos are able to recover once the chemical exposure has been 
removed.  Further studies are needed in adult zebrafish that were exposed to butylparaben 
as embryos, to see whether these islet deformities lead to insulin resistance later in life, 
and potentially the development of diabetes. The zebrafish is an ideal model to test for 
this because the diabetic zebrafish displays known secondary complications that are 
associated with diabetes in humans such as neuropathy, and impaired wound healing, 
which can be measured by caudal fin regeneration (Intine et al, 2013). Additionally, the 
zebrafish can regenerate its damaged pancreas and restore it to a similar state that would 
be expected in a post-transplant human patient (Intine et al, 2013). Analysis of glucose 
homeostasis can also be performed in adult zebrafish via blood analysis.  
However, very little is still known about the impact of environmental toxicant 
exposures on the developing pancreas and how oxidative stress impacts development. 
The results from these studies aim to contribute to the understanding of how exposure to 
an environmental toxicant, butylparaben, affects the developing pancreas. Future studies 
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are needed to investigate and whether oxidative stress is a mechanism that may impact 
the pancreas and lead to the development of disease, specifically diabetes, later in life.  
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